Newsroom

Default Image

Barron Witherspoon, Sr. Joins South Florida Speakers Bureau to Empower...

Barron Witherspoon, Sr., a renowned motivational speaker and the best-selling author of The Black Exec & The Seven Myths, has...

Jul 29, 2025 Press Release
Default Image

Firestorm Labs Secures $47M Series A Funding Led by NEA...

Firestorm Labs, a San Diego-based company specializing in advanced drones for warfare, has successfully closed a $47 million Series A...

Jul 29, 2025 Press Release
Default Image

Decisive Point Joins $47M Series A Funding for Firestorm Labs,...

Firestorm Labs, a San Diego-based innovator in advanced drone technology for warfare, has successfully closed a $47 million Series A...

Jul 29, 2025 Press Release
Default Image

Firestorm Labs Secures $47M Series A Funding to Advance Drone...

Firestorm Labs, a San Diego-based company specializing in advanced drones for warfare, has successfully closed a $47 million Series A...

Jul 29, 2025 Press Release
Default Image

Maryland Defends Offshore Wind Farm Permit Amid EPA Challenge

The Maryland Department of the Environment has reaffirmed its support for a permit issued to an offshore wind farm near...

Jul 29, 2025 Press Release
Default Image

ONAR Holding Corporation Strengthens Board with AI and Cybersecurity Expert...

ONAR Holding Corporation (OTCQB: ONAR), a prominent marketing technology company and agency network, has announced the appointment of Mark Gazit...

Jul 29, 2025 Press Release
Default Image

Nutriband Inc. Announces Key Dates for 25% Preferred Stock Dividend

Nutriband Inc. (NASDAQ: NTRB) has announced the key dates for its upcoming 25% preferred stock dividend, a move that underscores...

Jul 29, 2025 Press Release
Default Image

ESGold Corp. Showcased for Innovative Mining Strategy in NetworkNewsWire Feature

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) has been featured in a NetworkNewsWire editorial, emphasizing its innovative approach to mining that...

Jul 29, 2025 Press Release
Default Image

CNS Pharmaceuticals Inc. Announces 1-for-12 Reverse Stock Split

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a biopharmaceutical company dedicated to developing treatments for brain and central nervous system cancers, has...

Jul 29, 2025 Press Release